Archives of Endocrinology and Metabolism · 2020 · 10 citations · 25 references
MedicineEndocrinologyInternal MedicineAutoimmunityDiabetologyImmunopathologyAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune EndocrinopathiesDiabetes MellitusInsulin ResistanceAge-sex DistributionAnti-glutamic Acid Decarboxylase AntibodiesDiabetes DiagnosisFamily Health HistoryGlutamic Acid Decarboxylase AntibodiesInsulin Resistance Assessment
Objective: In this study, we aimed to determine the frequency of and the clinical and metabolic features of patients with latent autoimmune diabetes in adults (LADA) at a single center in Turkey. Subjects and methods: Patients over 30 years of age diagnosed with type 2 diabetes who did not require insulin for a minimum of 6 months following diagnosis were included. Data from 324 patients (163 women; 161 men), with a mean age of 54.97 7.53 years, were analyzed in the study. Levels of antibodies to glutamate decarboxylase (anti-GAD) were measured in all patients, and LADA was diagnosed in patients testing positive for anti-GAD antibodies. Results: Anti-GAD positivity was identified in 5 patients (1.5%). Family history of diabetes, body mass index (BMI), age, sex distribution, insulin resistance, serum triglycerides, high-density lipoprotein, and low-density lipoprotein were similar in the LADA and type 2 diabetes patients. Median HbA1c was significantly higher (10.8% vs. 7.38%, p = 0.002) and fasting C-peptide was lower (0.75 ng/mL vs. 2.82 ng/mL, p = 0.009) in patients with LADA compared to in those with type 2 diabetes. Among the 5 patients with LADA, 4 were positive for antithyroid peroxidase antibodies. The median disease duration was relatively shorter among patients with LADA (4 years vs. 7 years, p = 0.105). Conclusion: We observed a LADA frequency of 1.5% among Turkish patients followed for type 2 diabetes. The presence of obesity and metabolic syndrome did not exclude LADA, and patients with LADA had worse glycemic control than patients with type 2 diabetes did.
25
Population-Based Study of Diabetes and Risk Characteristics in Turkey
İlhan Satman, Temel Yılmaz, Ahmet M. Şengül et al. · Diabetes Care · 2002 · 537 citations · Full text
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
Mohammed I. Hawa, Charles Thivolet, Dı́dac Mauricio et al. · Diabetes Care · 2008 · 135 citations · Full text